Mankind Pharma Limited — JV/Acquisition, 21-05-2025: Acquisition

Mankind Pharma has announced a board meeting to consider the financial results for the quarter and half-year. The company completed a ₹13,768 Cr acquisition of 100% stake in Bharat Serums and Vaccines Limited, significantly boosting its presence in biotech and vaccines. With ₹7,362 Cr in net assets and ₹6,473 Cr goodwill, the deal enhances Mankind’s specialty pharma portfolio and diversifies revenue streams, positioning it strongly in life sciences.